Billiontoone (NASDAQ:BLLN) Shares Gap Down on Insider Selling

Billiontoone, Inc. (NASDAQ:BLLN) gapped down prior to trading on Thursday after an insider sold shares in the company. The stock had previously closed at $149.97, but opened at $105.16. Billiontoone shares last traded at $94.4910, with a volume of 803,215 shares traded.

Specifically, CEO Oguzhan Atay sold 12,500 shares of Billiontoone stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $137.37, for a total value of $1,717,125.00. Following the completion of the sale, the chief executive officer directly owned 162,500 shares in the company, valued at $22,322,625. This trade represents a 7.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $136.95, for a total transaction of $4,450,875.00. Following the completion of the transaction, the chief executive officer owned 20,000 shares in the company, valued at $2,739,000. This represents a 61.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In related news, insider Shan Riku Sakakibara sold 4,000 shares of the stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $140.21, for a total value of $560,840.00. Following the sale, the insider directly owned 200,000 shares in the company, valued at $28,042,000. This trade represents a 1.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Wall Street Analyst Weigh In

Several research analysts have weighed in on BLLN shares. Guggenheim assumed coverage on Billiontoone in a report on Monday, June 29th. They set a “buy” rating and a $125.00 target price on the stock. BTIG Research cut their price target on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday. JPMorgan Chase & Co. upped their price objective on Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Finally, Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 23rd. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $126.00.

Billiontoone News Roundup

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: BTIG Research maintained a Buy rating while lowering its price target from $142 to $130. The revised target still implies approximately 31% upside from the referenced share price, indicating the firm views the recent weakness as a buying opportunity. Benzinga analyst price target report
• Positive Sentiment: BillionToOne reported second-quarter EPS of $0.15, matching Wall Street expectations, and revenue of $109.45 million. The company also reiterated full-year 2026 revenue guidance of $450 million to $465 million, broadly consistent with the $453.3 million analyst consensus. BillionToOne second-quarter 2026 results
• Neutral Sentiment: The earnings release did not provide a clearly positive guidance increase, and the reported quarter met rather than exceeded expectations. With the stock trading at a high valuation, investors may have been looking for a stronger beat or upward revision to forecasts.
• Negative Sentiment: CEO Oguzhan Atay sold a combined 45,000 shares for approximately $6.17 million, reducing his holdings substantially. Although both transactions were executed under a pre-arranged Rule 10b5-1 plan, the size of the sales may weigh on sentiment. SEC filing for CEO stock sales
• Negative Sentiment: Insider Shan Riku Sakakibara separately sold 4,000 shares worth about $561,000. The sale was also pre-arranged, but it adds to a recent pattern of insider selling and may reinforce profit-taking concerns after BLLN’s strong run.
• Negative Sentiment: BTIG’s price-target reduction, despite its continued Buy rating, signals that the firm has moderated its near-term valuation expectations. This is particularly relevant as BillionToOne’s elevated price-to-earnings multiple leaves the stock sensitive to any sign of slowing growth or limited upside revisions.

Billiontoone Stock Performance

The company has a fifty day moving average of $116.73 and a two-hundred day moving average of $94.26. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92. The company has a market cap of $4.38 billion and a price-to-earnings ratio of 172.72.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting the consensus estimate of $0.15. The firm had revenue of $109.45 million for the quarter. Equities research analysts anticipate that Billiontoone, Inc. will post 0.92 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of BLLN. Rossby Financial LCC bought a new position in Billiontoone during the 4th quarter worth approximately $25,000. Wells Fargo & Company MN acquired a new position in shares of Billiontoone in the 4th quarter valued at about $76,000. Smartleaf Asset Management LLC acquired a new stake in Billiontoone during the fourth quarter worth approximately $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in Billiontoone in the fourth quarter valued at approximately $82,000. Finally, Renaissance Capital LLC bought a new position in Billiontoone during the fourth quarter worth $201,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.